111 related articles for article (PubMed ID: 34244239)
1. The Low-Expression Variant of
Dahlström EH; Saksi J; Forsblom C; Uglebjerg N; Mars N; Thorn LM; Harjutsalo V; Rossing P; Ahluwalia TS; Lindsberg PJ; Sandholm N; Groop PH;
Diabetes; 2021 Oct; 70(10):2391-2401. PubMed ID: 34244239
[TBL] [Abstract][Full Text] [Related]
2. Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability.
Saksi J; Ijäs P; Mäyränpää MI; Nuotio K; Isoviita PM; Tuimala J; Lehtonen-Smeds E; Kaste M; Jula A; Sinisalo J; Nieminen MS; Lokki ML; Perola M; Havulinna AS; Salomaa V; Kettunen J; Jauhiainen M; Kovanen PT; Lindsberg PJ
Circ Cardiovasc Genet; 2014 Oct; 7(5):588-98. PubMed ID: 25122052
[TBL] [Abstract][Full Text] [Related]
3. Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome.
Gormez S; Erdim R; Akan G; Caynak B; Duran C; Gunay D; Sozer V; Atalar F
Cardiovasc Pathol; 2020; 46():107192. PubMed ID: 31927390
[TBL] [Abstract][Full Text] [Related]
4. Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study.
Liu G; Ding M; Chiuve SE; Rimm EB; Franks PW; Meigs JB; Hu FB; Sun Q
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2259-2267. PubMed ID: 27609367
[TBL] [Abstract][Full Text] [Related]
5. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
[TBL] [Abstract][Full Text] [Related]
6. FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants.
Ibarretxe D; Girona J; Plana N; Cabré A; Heras M; Ferré R; Merino J; Vallvé JC; Masana L
Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):875-880. PubMed ID: 26141940
[TBL] [Abstract][Full Text] [Related]
7. Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes.
Syreeni A; El-Osta A; Forsblom C; Sandholm N; Parkkonen M; Tarnow L; Parving HH; McKnight AJ; Maxwell AP; Cooper ME; Groop PH;
Diabetes; 2011 Nov; 60(11):3073-80. PubMed ID: 21896933
[TBL] [Abstract][Full Text] [Related]
8. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community.
Kaess BM; Preis SR; Lieb W; Beiser AS; Yang Q; Chen TC; Hengstenberg C; Erdmann J; Schunkert H; Seshadri S; Vasan RS; ; Assimes TL; Deloukas P; Holm H; Kathiresan S; König IR; McPherson R; Reilly MP; Roberts R; Samani NJ; Stewart AF
J Am Heart Assoc; 2015 Mar; 4(3):e001544. PubMed ID: 25762803
[TBL] [Abstract][Full Text] [Related]
9. Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study.
Gedebjerg A; Bjerre M; Kjaergaard AD; Steffensen R; Nielsen JS; Rungby J; Friborg SG; Brandslund I; Thiel S; Beck-Nielsen H; Sørensen HT; Hansen TK; Thomsen RW
Diabetes Care; 2020 Sep; 43(9):2190-2198. PubMed ID: 32616614
[TBL] [Abstract][Full Text] [Related]
10. The impact of parental risk factors on the risk of stroke in type 1 diabetes.
Ylinen A; Hägg-Holmberg S; Eriksson MI; Forsblom C; Harjutsalo V; Putaala J; Groop PH; Thorn LM;
Acta Diabetol; 2021 Jul; 58(7):911-917. PubMed ID: 33721078
[TBL] [Abstract][Full Text] [Related]
11. Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study.
Bebu I; Keshavarzi S; Gao X; Braffett BH; Canty AJ; Herman WH; Orchard TJ; Dagogo-Jack S; Nathan DM; Lachin JM; Paterson AD;
Diabetes Care; 2021 Jun; 44(6):1309-1316. PubMed ID: 33883194
[TBL] [Abstract][Full Text] [Related]
12. The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study.
Xu T; Chen S; Yang F; Wang Y; Zhang K; Fu G; Zhang W
Acta Diabetol; 2021 Mar; 58(3):301-307. PubMed ID: 33113028
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between TCF7L2 gene variants and type 2 diabetes mellitus in a Brazilian sample of patients with the risk for cardiovascular disease.
Wunsch C; Dornelles TF; Girardi P; Arndt ME; Genro JP; Contini V
Endocr Regul; 2019 Jan; 53(1):1-7. PubMed ID: 31517619
[TBL] [Abstract][Full Text] [Related]
14. The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients.
Buraczynska M; Zukowski P; Ksiazek K; Wacinski P; Dragan M
Diabetes Res Clin Pract; 2016 Jun; 116():7-13. PubMed ID: 27321310
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes.
Qi L; Doria A; Manson JE; Meigs JB; Hunter D; Mantzoros CS; Hu FB
Diabetes; 2006 May; 55(5):1512-6. PubMed ID: 16644713
[TBL] [Abstract][Full Text] [Related]
16. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
[TBL] [Abstract][Full Text] [Related]
17. Smoking modifies the associated increased risk of future cardiovascular disease by genetic variation on chromosome 9p21.
Hamrefors V; Hedblad B; Hindy G; Smith JG; Almgren P; Engström G; Sjögren M; Gränsbo K; Orho-Melander M; Melander O
PLoS One; 2014; 9(1):e85893. PubMed ID: 24465769
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 gene polymorphism and risk of CVD in older patients with type 2 diabetes mellitus.
Buraczynska M; Ksiazek K; Zukowski P; Grzebalska A
Diabetes Res Clin Pract; 2016 Nov; 121():178-183. PubMed ID: 27741477
[TBL] [Abstract][Full Text] [Related]
19. Genetic links between diabetes mellitus and coronary atherosclerosis.
Ordovas JM
Curr Atheroscler Rep; 2007 Sep; 9(3):204-10. PubMed ID: 18241614
[TBL] [Abstract][Full Text] [Related]
20. Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease.
Rodríguez-Calvo R; Girona J; Alegret JM; Bosquet A; Ibarretxe D; Masana L
J Endocrinol; 2017 Jun; 233(3):R173-R184. PubMed ID: 28420707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
